Publications:

---

Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running?

Current Oncology (Toronto, Ont.)

Spitaleri, Gianluca G; Trillo Aliaga, Pamela P; Attili, Ilaria I; Del Signore, Ester E; Corvaja, Carla C; Corti, Chiara C; Crimini, Edoardo E; Passaro, Antonio A; de Marinis, Filippo F

Publication Date: 2023-05-16

Variant appearance in text: ALK: G1269A

PubMed Link: 37232842

Variant Present in the following documents:

• Main text
• curroncol-30-00384.pdf

View BVdb publication page

---

Epithelioid Inflammatory Myofibroblastic Sarcoma Presenting as Gastrointestinal Bleed: Case Report and Literature Review.

Jpgn Reports

Giannaki, Alexandra A; Doganis, Dimitrios D; Giamarelou, Panagiota P; Konidari, Anastasia A

Publication Date: 2021-02

Variant appearance in text: ALK: G1269A

PubMed Link: 37206935

Variant Present in the following documents:

• pg9-2-e019.pdf

View BVdb publication page

---

Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review.

Translational Lung Cancer Research

Meador, Catherine B CB; Piotrowska, Zofia Z

Publication Date: 2023-04-28

Variant appearance in text: ALK: G1269A

PubMed Link: 37197622

Variant Present in the following documents:

• tlcr-12-04-837.pdf

View BVdb publication page

---

Cerebrospinal fluid: A unique source of circulating tumor DNA with broad clinical applications.

Translational Oncology

Hickman, Richard A RA; Miller, Alexandra M AM; Arcila, Maria E ME

Publication Date: 2023-05-15

Variant appearance in text: ALK: G1269A

PubMed Link: 37196447

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page

---

EML4-ALK biology and drug resistance in Non-Small Cell Lung Cancer: a new phase of discoveries.

Molecular Oncology

Elshatlawy, Mariam M; Sampson, Josephina J; Clarke, Katy K; Bayliss, Richard R

Publication Date: 2023-05-07

Variant appearance in text: ALK: G1269A

PubMed Link: 37149843

Variant Present in the following documents:

• Main text
• MOL2-17-950.pdf

View BVdb publication page

---

Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma.

Nature Communications

Berko, Esther R ER; Witek, Gabriela M GM; Matkar, Smita S; Petrova, Zaritza O ZO; Wu, Megan A MA; Smith, Courtney M CM; Daniels, Alex A; Kalna, Joshua J; Kennedy, Annie A; Gostuski, Ivan I; Casey, Colleen C; Krytska, Kateryna K; Gerelus, Mark M; Pavlick, Dean D; Ghazarian, Susan S; Park, Julie R JR; Marachelian, Araz A; Maris, John M JM; Goldsmith, Kelly C KC; Radhakrishnan, Ravi R; Lemmon, Mark A MA; Mossé, Yaël P YP

Publication Date: 2023-05-05

Variant appearance in text: ALK: G1269A

PubMed Link: 37147298

Variant Present in the following documents:

• Main text
• 41467_2023_Article_38195.pdf

View BVdb publication page

---

Industry involvement in evidence production for genomic medicine: A bibliometric and funding analysis of decision impact studies.

Plos One

Parker, Gillian G; Hunter, Sarah S; Hogarth, Stuart S; Miller, Fiona A FA

Publication Date: 2023

Variant appearance in text: ALK: G1269A

PubMed Link: 37104298

Variant Present in the following documents:

• pone.0285122.s002.xlsx, sheet 1

View BVdb publication page

---

Strategies to overcome resistance to ALK inhibitors in non-small cell lung cancer: a narrative review.

Translational Lung Cancer Research

Desai, Aakash A; Lovly, Christine M CM

Publication Date: 2023-03-31

Variant appearance in text: ALK: G1269A

PubMed Link: 37057106

Variant Present in the following documents:

• Main text
• tlcr-12-03-615.pdf

View BVdb publication page

---

Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer.

Investigational New Drugs

Yang, Yingying Y; Zheng, Qingmei Q; Wang, Xinmei X; Zhao, Shuyong S; Huang, Wenshu W; Jia, Linchao L; Ma, Cuicui C; Liu, Shicong S; Zhang, Yongpeng Y; Xin, Qianqian Q; Sun, Yan Y; Zheng, Shansong S

Publication Date: 2023-04-10

Variant appearance in text: ALK: G1269A

PubMed Link: 37036582

Variant Present in the following documents:

• Main text
• 10637_2023_Article_1350.pdf

View BVdb publication page

---

Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib.

Frontiers In Oncology

Li, Mengmeng M; Xing, Ruyue R; Huang, Jiuyan J; Shi, Chao C; Wei, Chunhua C; Wang, Huijuan H

Publication Date: 2023

Variant appearance in text: ALK: G1269A

PubMed Link: 37035183

Variant Present in the following documents:

• Main text
• fonc-13-1084456.pdf

View BVdb publication page

---

Molecular Anatomy of the EML4-ALK Fusion Protein for the Development of Novel Anticancer Drugs.

International Journal Of Molecular Sciences

Cheon, So Yeong SY; Kwon, Sunghark S

Publication Date: 2023-03-18

Variant appearance in text: ALK: G1269A

PubMed Link: 36982897

Variant Present in the following documents:

• Main text
• ijms-24-05821.pdf

View BVdb publication page

---

Recent progress in targeted therapy for non-small cell lung cancer.

Frontiers In Pharmacology

Xiao, Yanxia Y; Liu, Pu P; Wei, Jie J; Zhang, Xin X; Guo, Jun J; Lin, Yajun Y

Publication Date: 2023

Variant appearance in text: ALK: G1269A

PubMed Link: 36909198

Variant Present in the following documents:

• Main text
• fphar-14-1125547.pdf

View BVdb publication page

---

First case report of ensartinib in a patient with metastatic ALK rearranged lung cancer with ALK I1171N mutation: a case report.

World Journal Of Surgical Oncology

Yang, Shuang S; Feng, Weineng W; Deng, Yanming Y; Liang, Jianmiao J

Publication Date: 2023-03-02

Variant appearance in text: ALK: G1269A

PubMed Link: 36864442

Variant Present in the following documents:

• Main text
• 12957_2023_Article_2935.pdf

View BVdb publication page

---

Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer.

Cancer Discovery

Pradat, Yoann Y; Viot, Julien J; Yurchenko, Andrey A AA; Gunbin, Konstantin K; Cerbone, Luigi L; Deloger, Marc M; Grisay, Guillaume G; Verlingue, Loic L; Scott, Veronique V; Padioleau, Ismael I; Panunzi, Leonardo L; Michiels, Stefan S; Hollebecque, Antoine A; Jules-Clement, Gerome G; Mezquita, Laura L; Laine, Antoine A; Loriot, Yohann Y; Besse, Benjamin B; Friboulet, Luc L; Andre, Fabrice F; Cournede, Paul-Henry PH; Gautheret, Daniel D; Nikolaev, Sergey I SI

Publication Date: 2023-03-02

Variant appearance in text: ALK: 3806G>C; G1269A; rs1057519781

PubMed Link: 36862804

Variant Present in the following documents:

• cd-22-0966_supplementary_tables_s1-s11_suppst1.xlsx, sheet 6

View BVdb publication page

---

Ensartinib in advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, two-staged, phase 1 trial.

Journal Of Thoracic Disease

Ma, Yuxiang Y; Pan, Hui H; Liu, Yu Y; Zhang, Yang Y; Hong, Shaodong S; Huang, Jianjin J; Weng, Shanshan S; Yang, Yunpeng Y; Fang, Wenfeng W; Huang, Yan Y; Xiao, Shanshan S; Wang, Tao T; Ding, Lieming L; Cui, Lingling L; Zhang, Li L; Zhao, Hongyun H

Publication Date: 2022-12

Variant appearance in text: ALK: G1269A

PubMed Link: 36647478

Variant Present in the following documents:

• Main text
• jtd-14-12-4751.pdf

View BVdb publication page

---

Pathological complete remission in ALK-positive lung cancer patient after multiple lines of conversion therapy.

Frontiers In Oncology

Que, Dan D; Zou, Hongbo H; Mao, Bijing B; Zhang, Huan H; Liang, Wei W; Liu, Qin Q; Ke, Leiyu L; Guo, Lijie L; Xie, Qichao Q

Publication Date: 2022

Variant appearance in text: ALK: G1269A

PubMed Link: 36523965

Variant Present in the following documents:

• Main text
• fonc-12-967675.pdf

View BVdb publication page

---

An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.

Frontiers In Immunology

Lin, Jing J; Liu, Jun J; Hao, Shi-Guang SG; Lan, Bin B; Zheng, Xiao-Bin XB; Xiong, Jia-Ni JN; Zhang, Ying-Qian YQ; Gao, Xuan X; Chen, Chuan-Ben CB; Chen, Ling L; Huang, Yu-Fang YF; Luo, Hong H; Yi, Yu-Ting YT; Yi, Xin X; Lu, Jian-Ping JP; Zheng, Xiong-Wei XW; Chen, Gang G; Wang, Xue-Feng XF; Chen, Yu Y

Publication Date: 2022

Variant appearance in text: ALK: 3806G>C; G1269A

PubMed Link: 36505399

Variant Present in the following documents:

• Table_2.xlsx, sheet 2

View BVdb publication page

---

Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance.

International Journal Of Molecular Sciences

Wu, Jiajia J; Lin, Zhenghong Z

Publication Date: 2022-12-01

Variant appearance in text: ALK: G1269A

PubMed Link: 36499382

Variant Present in the following documents:

• Main text
• ijms-23-15056.pdf

View BVdb publication page

---

Ceritinib (LDK378) prevents bone loss via suppressing Akt and NF-κB-induced osteoclast formation.

Frontiers In Endocrinology

He, Wenxin W; Cao, Xiankun X; Kong, Keyu K; Rong, Kewei K; Han, Shuai S; Qin, An A

Publication Date: 2022

Variant appearance in text: ALK: Gly1269Ala

PubMed Link: 36425467

Variant Present in the following documents:

• Main text
• fendo-13-939959.pdf

View BVdb publication page

---

Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma.

Frontiers In Oncology

Pasau, Thomas T; Wauters, Els E; Wauters, Isabelle I; Duplaquet, Fabrice F; Pirard, Lionel L; Pop-Stanciu, Claudia C; D'Haene, Nicky N; Dupont, Michael M; Vander Borght, Thierry T; Rondelet, Benoît B; Ocak, Sebahat S

Publication Date: 2022

Variant appearance in text: ALK: G1269A

PubMed Link: 36419902

Variant Present in the following documents:

• Main text
• fonc-12-985446.pdf

View BVdb publication page

---

Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer.

Frontiers In Oncology

Fang, Xiaoxu X; Yu, Shaokun S; Jiang, Yingying Y; Xiang, Yan Y; Lu, Kaihua K

Publication Date: 2022

Variant appearance in text: ALK: G1269A

PubMed Link: 36387176

Variant Present in the following documents:

• Main text
• fonc-12-1027664.pdf

View BVdb publication page

---

Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer.

Current Oncology (Toronto, Ont.)

Xiang, Yan Y; Zhang, Shiyu S; Fang, Xiaoxu X; Jiang, Yingying Y; Fang, Tingwen T; Liu, Jinwen J; Lu, Kaihua K

Publication Date: 2022-10-16

Variant appearance in text: ALK: G1269A

PubMed Link: 36290895

Variant Present in the following documents:

• Main text
• curroncol-29-00618.pdf

View BVdb publication page

---

Histone deacetylases modulate resistance to the therapy in lung cancer.

Frontiers In Genetics

Contreras-Sanzón, Estefanía E; Prado-Garcia, Heriberto H; Romero-Garcia, Susana S; Nuñez-Corona, David D; Ortiz-Quintero, Blanca B; Luna-Rivero, Cesar C; Martínez-Cruz, Victor V; Carlos-Reyes, Ángeles Á

Publication Date: 2022

Variant appearance in text: ALK: G1269A

PubMed Link: 36263432

Variant Present in the following documents:

• Main text
• fgene-13-960263.pdf

View BVdb publication page

---

Small molecule inhibitors targeting the cancers.

Medcomm

Liu, Gui-Hong GH; Chen, Tao T; Zhang, Xin X; Ma, Xue-Lei XL; Shi, Hua-Shan HS

Publication Date: 2022-12

Variant appearance in text: ALK: Gly1269Ala

PubMed Link: 36254250

Variant Present in the following documents:

• Main text
• MCO2-3-e181.pdf

View BVdb publication page

---

The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives.

Cancers

Cognigni, Valeria V; Pecci, Federica F; Lupi, Alessio A; Pinterpe, Giada G; De Filippis, Chiara C; Felicetti, Cristiano C; Cantini, Luca L; Berardi, Rossana R

Publication Date: 2022-09-29

Variant appearance in text: ALK: G1269A

PubMed Link: 36230686

Variant Present in the following documents:

• Main text
• cancers-14-04765.pdf

View BVdb publication page

---

Molecular targeted therapy for anticancer treatment.

Experimental & Molecular Medicine

Min, Hye-Young HY; Lee, Ho-Young HY

Publication Date: 2022-10

Variant appearance in text: ALK: G1269A

PubMed Link: 36224343

Variant Present in the following documents:

• Main text
• 12276_2022_Article_864.pdf

View BVdb publication page

---

Case report: Durable response to alectinib in ALK-rearranged lung adenocarcinoma with acquired, crizotinib-resistant ALK C1156F mutation.

Frontiers In Oncology

Rao, Chuangzhou C; Nie, Liangqin L; Wu, Xiaokang X; Miao, Xiaobo X; Chen, Ting T; Chen, Liuxi L; Zhang, Dongqing D; Lin, Quan Q

Publication Date: 2022

Variant appearance in text: ALK: G1269A

PubMed Link: 36203454

Variant Present in the following documents:

• Main text
• fonc-12-915502.pdf

View BVdb publication page

---

Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers.

Bmc Cancer

Wu, Huita H; Ji, Haonan H; Yang, Wenhui W; Zhang, Min M; Guo, Yifang Y; Li, Bangkai B; Wang, Jiayin J; Chen, Rongrong R; Chen, Yuan Y; Wang, Xin X

Publication Date: 2022-09-27

Variant appearance in text: ALK: G1269A

PubMed Link: 36167530

Variant Present in the following documents:

• 12885_2022_9922_MOESM5_ESM.xlsx, sheet 1

View BVdb publication page

---

Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single-center retrospective study.

Thoracic Cancer

Kunimasa, Kei K; Sugimoto, Naotoshi N; Kawamura, Takahisa T; Yamasaki, Tomoyuki T; Honma, Keiichiro K; Nagata, Shigenori S; Kukita, Yoji Y; Fujisawa, Fumie F; Inoue, Tazuko T; Yamaguchi, Yuko Y; Kitasaka, Mitsuko M; Wakamatsu, Toru T; Yamai, Takuo T; Yamamoto, Sachiko S; Hayashi, Takuji T; Inoue, Takako T; Tamiya, Motohiro M; Imamura, Fumio F; Nishimura, Kazuo K; Nishino, Kazumi K

Publication Date: 2022-11

Variant appearance in text: ALK: G1269A

PubMed Link: 36100256

Variant Present in the following documents:

• Main text
• TCA-13-2970.pdf

View BVdb publication page

---

DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapy.

Experimental & Molecular Medicine

Heo, Haejeong H; Kim, Jong-Hwan JH; Lim, Hyun Jung HJ; Kim, Jeong-Hwan JH; Kim, Miso M; Koh, Jaemoon J; Im, Joo-Young JY; Kim, Bo-Kyung BK; Won, Misun M; Park, Ji-Hwan JH; Shin, Yang-Ji YJ; Yun, Mi Ran MR; Cho, Byoung Chul BC; Kim, Yong Sung YS; Kim, Seon-Young SY; Kim, Mirang M

Publication Date: 2022-08

Variant appearance in text: ALK: G1269A

PubMed Link: 35999456

Variant Present in the following documents:

• 12276_2022_836_MOESM1_ESM.pdf

View BVdb publication page

---

AACR Project GENIE: 100,000 Cases and Beyond.

Cancer Discovery

Pugh, Trevor J TJ; Bell, Jonathan L JL; Bruce, Jeff P JP; Doherty, Gary J GJ; Galvin, Matthew M; Green, Michelle F MF; Hunter-Zinck, Haley H; Kumari, Priti P; Lenoue-Newton, Michele L ML; Li, Marilyn M MM; Lindsay, James J; Mazor, Tali T; Ovalle, Andrea A; Sammut, Stephen-John SJ; Schultz, Nikolaus N; Yu, Thomas V TV; Sweeney, Shawn M SM; Bernard, Brady B; ,

Publication Date: 2022-09-02

Variant appearance in text: ALK: G1269A

PubMed Link: 35819403

Variant Present in the following documents:

• cd-21-1547_supplementary_table_1_suppst1.xlsx, sheet 1

View BVdb publication page

---

Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study.

Frontiers In Oncology

Shen, Fangfang F; Liang, Naixin N; Fan, Zaiwen Z; Zhao, Min M; Kang, Jing J; Wang, Xifang X; Hu, Qun Q; Mu, Yongping Y; Wang, Kai K; Yuan, Mingming M; Chen, Rongrong R; Guo, Wei W; Dong, Guilan G; Zhao, Jun J; Bai, Jun J

Publication Date: 2022

Variant appearance in text: ALK: G1269A

PubMed Link: 35814426

Variant Present in the following documents:

• DataSheet_1.xlsx, sheet 2

View BVdb publication page

---

The Change in Paradigm for NSCLC Patients with EML4-ALK Translocation.

International Journal Of Molecular Sciences

Bearz, Alessandra A; De Carlo, Elisa E; Del Conte, Alessandro A; Spina, Michele M; Da Ros, Valentina V; Bertoli, Elisa E; Revelant, Alberto A; Stanzione, Brigida B; Tirelli, Umberto U

Publication Date: 2022-06-30

Variant appearance in text: ALK: G1269A

PubMed Link: 35806325

Variant Present in the following documents:

• Main text
• ijms-23-07322.pdf

View BVdb publication page

---

The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of 2nd/3rd-Generation ALK Tyrosine Kinase Inhibitors (TKIs).

Frontiers In Oncology

Raphael, Ari A; Onn, Amir A; Holtzman, Liran L; Dudnik, Julia J; Urban, Damien D; Kian, Waleed W; Cohen, Aharon Y AY; Moskovitz, Mor M; Zer, Alona A; Bar, Jair J; Rabinovich, Natalie Maimon NM; Grynberg, Shirly S; Oedegaard, Cecilie C; Agbarya, Abed A; Peled, Nir N; Shochat, Tzippy T; Dudnik, Elizabeth E

Publication Date: 2022

Variant appearance in text: ALK: G1269A

PubMed Link: 35646707

Variant Present in the following documents:

• Table_2.xlsx, sheet 1

View BVdb publication page

---

Targeting ALK Rearrangements in NSCLC: Current State of the Art.

Frontiers In Oncology

Peng, Ling L; Zhu, Liping L; Sun, Yilan Y; Stebbing, Justin J; Selvaggi, Giovanni G; Zhang, Yongchang Y; Yu, Zhentao Z

Publication Date: 2022

Variant appearance in text: ALK: G1269A

PubMed Link: 35463328

Variant Present in the following documents:

• Main text
• fonc-12-863461.pdf

View BVdb publication page

---

Culture and multiomic analysis of lung cancer patient-derived pleural effusions revealed distinct druggable molecular types.

Scientific Reports

Seo, Ha-Young HY; Kim, Soon-Chan SC; Roh, Woo-Lee WL; Shin, Young-Kyoung YK; Kim, Soyeon S; Kim, Dong-Wan DW; Kim, Tae Min TM; Ku, Ja-Lok JL

Publication Date: 2022-04-15

Variant appearance in text: ALK: G1269A

PubMed Link: 35428753

Variant Present in the following documents:

• Main text
• 41598_2022_Article_10318.pdf

View BVdb publication page

---

Successful treatment of refractory brain metastases from ALK-positive lung cancer with lorlatinib.

Thoracic Cancer

Nakagawa, Yoshiko Y; Shimizu, Tetsuo T; Hiranuma, Hisato H; Gon, Yasuhiro Y

Publication Date: 2022-05

Variant appearance in text: ALK: G1269A

PubMed Link: 35373538

Variant Present in the following documents:

• Main text
• TCA-13-1431.pdf

View BVdb publication page

---

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.

Nature Cancer

Tamborero, David D; Dienstmann, Rodrigo R; Rachid, Maan Haj MH; Boekel, Jorrit J; Lopez-Fernandez, Adria A; Jonsson, Markus M; Razzak, Ali A; Braña, Irene I; De Petris, Luigi L; Yachnin, Jeffrey J; Baird, Richard D RD; Loriot, Yohann Y; Massard, Christophe C; Martin-Romano, Patricia P; Opdam, Frans F; Schlenk, Richard F RF; Vernieri, Claudio C; Masucci, Michele M; Villalobos, Xenia X; Chavarria, Elena E; , ; Balmaña, Judith J; Apolone, Giovanni G; Caldas, Carlos C; Bergh, Jonas J; Ernberg, Ingemar I; Fröhling, Stefan S; Garralda, Elena E; Karlsson, Claes C; Tabernero, Josep J; Voest, Emile E; Rodon, Jordi J; Lehtiö, Janne J

Publication Date: 2022-02

Variant appearance in text: ALK: Gly1269Ala

PubMed Link: 35221333

Variant Present in the following documents:

• 43018_2022_332_MOESM3_ESM.xlsx, sheet 1

View BVdb publication page

---

Challenges in the Use of Targeted Therapies in Non-Small Cell Lung Cancer.

Cancer Research And Treatment

Rivera-Concepcion, Joel J; Uprety, Dipesh D; Adjei, Alex A AA

Publication Date: 2022-04

Variant appearance in text: ALK: G1269A

PubMed Link: 35209703

Variant Present in the following documents:

• crt-2022-078.pdf

View BVdb publication page

---

Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer.

International Journal Of Molecular Sciences

Haider, Mohamed M; Elsherbeny, Amr A; Pittalà, Valeria V; Consoli, Valeria V; Alghamdi, Maha Ali MA; Hussain, Zahid Z; Khoder, Ghalia G; Greish, Khaled K

Publication Date: 2022-02-06

Variant appearance in text: ALK: G1269A

PubMed Link: 35163777

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer.

International Journal Of Molecular Sciences

Haider, Mohamed M; Elsherbeny, Amr A; Pittalà, Valeria V; Consoli, Valeria V; Alghamdi, Maha Ali MA; Hussain, Zahid Z; Khoder, Ghalia G; Greish, Khaled K

Publication Date: 2022-02-06

Variant appearance in text: ALK: G1269A

PubMed Link: 35163777

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Real-world circulating tumor DNA analysis depicts resistance mechanism and clonal evolution in ALK inhibitor-treated lung adenocarcinoma patients.

Esmo Open

Hua, G G; Zhang, X X; Zhang, M M; Wang, Q Q; Chen, X X; Yu, R R; Bao, H H; Liu, J J; Wu, X X; Shao, Y Y; Liang, B B; Lu, K K

Publication Date: 2022-02-02

Variant appearance in text: ALK: G1269A

PubMed Link: 35123209

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Real-world circulating tumor DNA analysis depicts resistance mechanism and clonal evolution in ALK inhibitor-treated lung adenocarcinoma patients.

Esmo Open

Hua, G G; Zhang, X X; Zhang, M M; Wang, Q Q; Chen, X X; Yu, R R; Bao, H H; Liu, J J; Wu, X X; Shao, Y Y; Liang, B B; Lu, K K

Publication Date: 2022-02

Variant appearance in text: ALK: G1269A

PubMed Link: 35123209

Variant Present in the following documents:

• Main text

View BVdb publication page

---